Cargando…
Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
BACKGROUND: To conduct an economic evaluation comparing ranolazine as add-on therapy to standard-of-care (SoC) with SoC alone in patients with stable angina who did not respond adequately to first line therapy, in Greece. METHODS: A decision tree model was locally adapted in the Greek setting to eva...
Autores principales: | Kourlaba, Georgia, Vlachopoulos, Charalambos, Parissis, John, Kanakakis, John, Gourzoulidis, George, Maniadakis, Nikos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683812/ https://www.ncbi.nlm.nih.gov/pubmed/26684327 http://dx.doi.org/10.1186/s12913-015-1228-y |
Ejemplares similares
-
Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016) -
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014) -
Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013) -
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014) -
Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013)